Overexpression of <i>BCL2</i>, <i>BCL6</i>, <i>VEGFR1</i> and <i>TWIST1</i> in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival.
Journal Information
Full Title: Onco Targets Ther
Abbreviation: Onco Targets Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosure The authors report no conflicts of interest in this work."
Funding Disclosure
Evidence found in paper:
"Rafael Cerón is grateful to CONACYT for a scholarship (CVU #744744) and to Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México for academic formation. This study was supported by AMGEN (20187475) and Hospital General de México (DI/19/103/03/006 and DI/16/103/03/035)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025